THE EUROPEAN HEAD AND NECK SOCIETY and the European Cancer Patient Coalition called for the implementation of a Europe-wide head and neck cancer early diagnosis awareness program in the European Parliament.
THE FDA DRUG SHORTAGE ASSISTANCE AWARD… There is such a thing!
LISA STOCKMON joined City of Hope as chief marketing and communications officer.
THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY published a detailed factsheet about federal research funding in nearly 400 congressional districts.
BETH ISRAEL DEACONESS MEDICAL CENTER and Cancer Genetics Inc. entered into a collaboration to correlate genomic profiles to outcomes in diffuse large B-cell lymphoma.
FDA awarded The Critical Path Institute $2.1 million for the first year of funding of a five-year grant.
THE WEST CLINIC received the National Committee for Quality Assurance Recognition as a Patient-Centered Specialty Practice for its responsiveness to patients and medical colleagues, cooperation and integration with other health care groups, and dedication to continuous improvement.
CITY OF HOPE and Wilshire Oncology Medical Group have reached an agreement in which Wilshire physicians will join City of Hope Medical Group in California, delivering care to patients through new community practice sites in Glendora, Pomona, Rancho Cucamonga, West Covina and Corona.
MARGARET FOTI, chief executive officer of the American Association for Cancer Research, received the Ellen V. Sigal Advocacy Leadership Award from Friends of Cancer Research at its Cancer Leadership Awards Reception in Washington, D.C.
THE LEUKEMIA AND LYMPHOMA SOCIETY and OncoPep entered a partnership to advance an experimental cancer vaccine to treat patients with smoldering multiple myeloma, an asymptomatic stage of myeloma. The partnership is through the society's Therapy Acceleration Program.
